Arginine Starvation and Docetaxel Induce C-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-0206
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Expression Profile of microRNAs in C-Myc Induced Mouse Mammary Tumors

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

MYC-driven Small Cell Lung Cancer Is Metabolically Distinct and Vulnerable to Arginine Depletion

Clinical Cancer Research
Cancer ResearchOncology
2019English

Expression of C-Myc and Mutation of the KRAS Gene in Patients With Ovarian Mucinous Tumors

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2019English

The Super Elongation Complex May Be Targetable in MYC-Driven Tumors

Cancer Discovery
Oncology
2018English

MYC-Driven Tumors Are Dependent on CDK9-Mediated Transcription Elongation

Cancer Discovery
Oncology
2014English

Targeting the Warburg Effect With a Novel Glucose Transporter Inhibitor to Overcome Gemcitabine Resistance in Pancreatic Cancer Cells

Carcinogenesis
MedicineCancer Research
2014English

Posterior Segment Toxicity After Gemcitabine and Docetaxel Chemotherapy

Optometry and Vision Science
OptometryOphthalmology
2015English

Dominant-Negative TAK1 Induces C-Myc and G0 Exit in Liver

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy